1. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes
   László Bányai et al, 2021, eLife CrossRef
2. Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma
   Damla Isci et al, 2021, Cancers CrossRef
3. The prospect of tumor microenvironment-modulating therapeutical strategies
   Dirk Eulberg et al, 2022, Frontiers in Oncology CrossRef
4. Chemokine Receptor Antagonists: Role in Oncology
   Sean Kraus et al, 2021, Current Oncology Reports CrossRef
5. The Adipose Stem Cell as a Novel Metabolic Actor in Adrenocortical Carcinoma Progression: Evidence from an In Vitro Tumor Microenvironment Crosstalk Model
   Roberta Armignacco et al, 2019, Cancers CrossRef
6. Chemokine signaling in cancer-stroma communications
   Arun J. Singh et al, 2021, Journal of Cell Communication and Signaling CrossRef
7. The Role of ACKR3 in Breast, Lung, and Brain Cancer
   Maria Neves et al, 2019, Molecular Pharmacology CrossRef
8. CXCR7 Inhibits Fibrosis via Wnt/β-Catenin Pathways during the Process of Angiogenesis in Human Umbilical Vein Endothelial Cells
   MinQian Shen et al, 2020, BioMed Research International CrossRef
9. C-X-C Chemokine Receptor Type 7 (CXCR-7) Expression in Invasive Ductal Carcinoma of Breast in Association with Clinicopathological Features
   Roshanak Shams et al, 2020, Pathology & Oncology Research CrossRef
10. Adipocyte-Specific ACKR3 Regulates Lipid Levels in Adipose Tissue
    Selin Gencer et al, 2021, Biomedicines CrossRef
11. The Signaling Pathways Associated With Breast Cancer Bone Metastasis
    Xuelian Song et al, 2022, Frontiers in Oncology CrossRef
12. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
    Dina Morein et al, 2020, Frontiers in Immunology CrossRef
13. Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity
    Elnaz Menhaji-Klotz et al, 2020, ACS Medicinal Chemistry Letters CrossRef